Purchase Order 75D30123P17401
Award Date 9/14/23
Potential Completion Date 9/29/23
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $11,400 by the Centers for Disease Control and Prevention (CDC) Pittsburgh on January 27, 2021. The contract, with an ultimate completion date of February 15, 2021, was issued without a set-aside designation, reflecting Illumina's specialized position as a technology provider for sequencing...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, for the provision of lab supplies. The $16,168.00 contract has an April 29, 2024 completion date and was awarded on August 22, 2019. The lab supplies are to be delivered to the CDC's location in Atlanta, GA. Illumina is a for-profit organization and manufacturer that has previously...
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $51,750.47, is to provide the CDC's Pittsburgh facility with Illumina's advanced DNA and RNA sequencing instruments, reagents, consumables, maintenance services, and bioinformatics software. The contract is not associated with a set-aside...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...
- The CDC Pittsburgh awarded a $29,595.03 firm fixed-price purchase order to Illumina, Inc. on August 9, 2024, for NextEra XT Library Preparation kits and related reagent supplies required for the agency's validated MiSeq Next-Generation Sequencing (NGS) assay. This assay supports the identification of HIV genetic mutations associated with drug resistance—a critical capability for HIV surveillance and treatment optimization. The contract, which carries no set-aside designation, will be performed...
- The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...